Title : Sulfonylurea Class of Antidiabetic Drugs Inhibit Acetylcholinesterase Activity: Unexplored Auxiliary Pharmacological Benefit toward Alzheimer's Disease - Baruah_2021_ACS.Pharmacol.Transl.Sci_4_193 |
Author(s) : Baruah P , Das A , Paul D , Chakrabarty S , Aguan K , Mitra S |
Ref : ACS Pharmacol Transl Sci , 4 :193 , 2021 |
Abstract : Baruah_2021_ACS.Pharmacol.Transl.Sci_4_193 |
ESTHER : Baruah_2021_ACS.Pharmacol.Transl.Sci_4_193 |
PubMedSearch : Baruah_2021_ACS.Pharmacol.Transl.Sci_4_193 |
PubMedID: 33615172 |
Baruah P, Das A, Paul D, Chakrabarty S, Aguan K, Mitra S (2021)
Sulfonylurea Class of Antidiabetic Drugs Inhibit Acetylcholinesterase Activity: Unexplored Auxiliary Pharmacological Benefit toward Alzheimer's Disease
ACS Pharmacol Transl Sci
4 :193
Baruah P, Das A, Paul D, Chakrabarty S, Aguan K, Mitra S (2021)
ACS Pharmacol Transl Sci
4 :193